NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018

Restricted access

Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.

Provided content development and/or authorship assistance.

Supplementary Materials

    • Supplemental Material (PDF 302 KB)
    • Supplemental Material (PDF 163 KB)
All Time Past Year Past 30 Days
Abstract Views 3 0 0
Full Text Views 8788 6415 359
PDF Downloads 4098 3021 165
EPUB Downloads 0 0 0